Skip to content
The Decision
After reviewing robust records and relentless advocacy from the Natural Products Association, the FDA acknowledged what many of us already knew: NMN has been marketed rightfully as a dietary supplement in the United States since 2017. This isn't just bureaucratic backtracking: it's a binding acknowledgment that NMN fits squarely within DSHEA's definition of a dietary supplement.
The agency's reversal didn't happen in a vacuum. It took citizen petitions, federal litigation, and frankly, a fair bit of fortitude from everyone who refused to accept the 2022 ruling at face value. Sometimes standing your ground pays off.
What This Actually Means
Here's what this decision means in practical terms:
- NMN returns to major platforms (including online marketplaces that have restricted it's sale)
- Manufacturing and quality standards remain rigorous and regulated
- No more regulatory grey areas
- Research can accelerate without the specter of sudden shutdowns
- Community confidence can be based on a more solid foundation
- The precedent potentially protects other promising compounds
This historic decision has implications that reach far beyond the legality of NMN as a supplement. It is an indication of further safeguards to scientific innovation and market freedom to access the meaningful compounds that make a real difference in our lives.
Our Commitment Continues
Throughout this tumultuous time, we've stayed the course. No shortcuts, no compromises, just consistent quality while we waited for wisdom to win out. Today feels like vindication, but honestly?
We never doubted this day would come.
To everyone who stuck with us, who sent supportive emails, who shared the science when skeptics surfaced: this victory is yours too.
Here's to clarity, continuity, and the cellular support you deserve.
